Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update.Change of auditorsOn October 10, 2025, the Company announced that Davidson & Company LLP ("Davidson") had resigned as the Company's independent auditor of its own...
2025-12-01 5:00 PM EST
Numinus Wellness Announces Change of Auditor
Vancouver, British Columbia--(Newsfile Corp. - October 10, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, announces that Davidson & Company LLP ("Davidson") has resigned as the Company's independent auditor of its own initiative, and that MNP LLP ("MNP") has been engaged as the Company's new independent...
2025-10-10 5:00 PM EDT
Numinus Wellness Inc. Announces Third Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company") a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended May 31, 2025 ("Q3 2025 ")."The progress we are making in fiscal 2025 demonstrates our success in shifting to a leaner...
2025-09-03 7:00 AM EDT
Numinus Wellness Inc. Announces Second Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended February 28, 2025 ("Q2 2025").Q2 2025 Performance Metrics
2025-08-20 5:24 PM EDT
Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results
Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, today announced its financial results for the three months ended November 30, 2024 ("Q1 2025").Q1 2025 Performance Metrics
2025-08-08 5:00 PM EDT
Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results
Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of $0.3 million, compared to a loss of $0.05 million in Q3 2024Cash position of $2.0 million as of August 31, 2024Subsequent to Quarter EndOn December 12, 2024, the Company closed on the sale of its wellness clinic network to Stella, an interventional psychiatry practice, for a total consideration of US$3.53 million. As a result of the transaction, the Company's U.S. Clinic Network operating segment...
2025-07-25 6:01 PM EDT
Numinus Clarifies Disclosures
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, wishes to clarify two news releases disseminated on May 30, 2024, titled "Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder"...
2024-06-07 9:09 PM EDT
Numinus Wellness Charts Path To Profitability While Strengthening Community Ties
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus'' or the "Company"), a leader in mental health care and in advancing evidence-based psychedelic-assisted therapies, announces a strategic blueprint aimed at fortifying its footprint across the United States.Through a comprehensive cost optimization initiative, Numinus is poised to strengthen its already established network of U.S. wellness clinics and cutting-edge clinical...
2024-05-30 9:09 AM EDT
Numinus and Cybin Embark on a Groundbreaking Journey: Pioneering Phase 3 Trials for Major Depressive Disorder
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23) has proudly announced that its research site, Cedar Clinical Research (CCR), has been selected for Cybin's Phase 3 pivotal multinational clinical trial of CYB003. Aimed at revolutionizing the treatment of Major Depressive Disorder (MDD), this collaboration marks a pivotal moment in the journey toward...
2024-05-30 9:08 AM EDT